Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells

Author(s): Hou XL, Takahashi K, Kinoshita N, Qiu F, Tanaka K, et al.


Curcuma longa and C. zedoaria, belonging to genus Curcuma, have become prevalent as supplements in East Asia. Curcumin is the most well-studied bioactive component isolated from rhizomes of C. longa and other Curcuma species except C. zedoaria. In this study, we investigated the affects of C. longa, C. zedoaria from Japan and curcumin on CYP3A4. Caco-2 cells, in which CYP3A4 expression was induced by 1alpha,25-(OH)(2)-D(3), were used to mimic the metabolism of small intestine. Caco-2 cells were treated with methanol extracts from two Curcuma rhizomes (0.1mg/ml) or curcumin (30 microM) for 72 h. Both extracts significantly decreased the activity of CYP3A4 by about 85-98%. The 50% inhibitory concentrations of C. longa and C. zedoaria extracts were 0.019 and 0.014 mg/ml, respectively. They caused a 60-70% decrease in CYP3A4 protein. Otherwise, curcumin treatment caused a 30-40% decrease in CYP3A4 catalytic activity and a 38% decrease in CYP3A4 protein expression. Moreover, it was found that both Curcuma extracts and curcumin treatment had no influence on CYP3A4 mRNA expression. Our results suggested that administration of Curcuma drugs might inhibit the catalytic activity of intestinal CYP3A4. However, curcumin was not the major compound responsible for this inhibitory effect.

Similar Articles

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

Author(s): Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, et al.

Systematic review of herbs and dietary supplements for glycemic control in diabetes

Author(s): Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS

Curcumin: From ancient medicine to current clinical trials

Author(s): Hatcher H, Planalp R, Cho J, Torti FM, Torti SV

Evaluation of liposomal curcumin cytochrome p450 metabolism

Author(s): Mach CM, Chen JH, Mosley SA, Kurzrock R, Smith JA

Liquid chromatographic method for the determination of rosiglitazone in human plasma

Author(s): Kolte BL, Raut BB, Deo AA, Bagool MA, Shinde DB

Hypoglycaemic effect of Artemisia herba alba

Author(s): al-Shamaony L, al-Khazraji SM, Twaij HA

Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver

Author(s): Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP

Compounds isolated from Curcuma aromatica Salisb

Author(s): Bamba Y, Yun YS, Kunugi A, Inoue H

Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products

Author(s): Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, Vermeulen NP

Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues

Author(s): Appiah-Opong R, de Esch I, Commandeur JN, Andarini M, Vermeulen NP

Bioavailability of curcumin: problems and promises

Author(s): Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB

Curcumin therapeutic promises and bioavailability in colorectal cancer

Author(s): Shehzad A, Khan S, Shehzad O, Lee YS

Pharmacokinetics and Pharmacodynamics of Curcumin

Author(s): Sharma RA, Steward WP, Gescher AJ

Evaluation of liposomal curcumin cytochrome p450 metabolism

Author(s): Mach CM, Chen JH, Mosley SA, Kurzrock R, Smith JA